Streetbeat News

Partnerships

AMZN

CSCO

GOOG

MSFT

NVDA

Cisco Systems Inc (CSCO) announced a 5% workforce reduction, approximately 4,250 jobs, as it enters 2024 alongside tech giants like Alphabet (GOOG), Amazon.com Inc (AMZN), and Microsoft Corporation (MSFT) in making job cuts. Despite expanding its AI and cybersecurity partnership with Nvidia Corporation (NVDA) to focus on data centers, Cisco's positive news was overshadowed by a modest forecast for the current quarter and full year. Cisco's fiscal second quarter saw a 6% YoY revenue decline and a cautious outlook due to macroeconomic challenges and supply chain issues. The company also plans to acquire Splunk to diversify from its networking equipment business.

Portfolio Pulse from Upwallstreet

February 20, 2024 | 1:30 pm

SKIL

Skillsoft (NYSE:SKIL) announced enhancements to its Codecademy platform, integrating generative AI (GenAI) to provide immersive technology skills training. The updates include AI-powered capabilities like prompt engineering functionality, code explanations, project hints, a mock interview simulator, and a virtual coding assistant. These enhancements aim to help learners and organizations build critical technology skills for the AI era. Skillsoft also plans to expand its curricula to include more AI skills training, with new courses on prompt engineering for various professions.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 1:24 pm

CNHI

CNH Industrial (CNHI) has taken a minority investment in Bem Agro, a Brazilian AI company specializing in drone imaging for agriculture. This investment aims to enhance CNH's Ag Tech solutions, making farming more efficient and sustainable. Bem Agro's technology, which has been in commercial partnership with CNH for over five years, provides Agronomic Mapping Reports from aerial images to optimize farming operations. The technology is already integrated into CNH's Case IH and New Holland brands in Brazil, Indonesia, and Thailand, aiming to expand its precision technology solutions across Latin America and Asia Pacific.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 1:20 pm

BNZI

Banzai International, Inc. (NASDAQ:BNZI) reported a December 2023 ARR of $4.6M and targets a December 2024 ARR of $8.1M-$10M. The company executed an LOI to acquire Mixed Analytics, aiming to enhance its MarTech solutions. This acquisition, along with others under LOI, is expected to contribute to the targeted ARR growth. Banzai's strategy includes organic growth and acquisitions, with a significant increase in ARR anticipated by the end of 2024.

Portfolio Pulse from Happy Mohamed

February 20, 2024 | 1:18 pm

BFRI

Biofrontera Inc. (BFRI) has announced a significant restructuring of its supply agreement with Biofrontera AG, including a substantial reduction in the transfer price of Ameluz to Biofrontera AG. Additionally, control of all US clinical trials of Ameluz will transfer to Biofrontera Inc. effective June 1.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 1:16 pm

LYFT

MSFT

SBUX

UBER

Lyft Inc (NASDAQ:LYFT) reported better-than-expected 2023 financials, with a significant stock surge followed by a sharp fall due to a corrected earnings typo. Despite this, Lyft's strategic partnerships with Starbucks (NASDAQ:SBUX) and Microsoft's LinkedIn (NASDAQ:MSFT) and strong financial performance indicate profitable growth ahead. In contrast, Uber Technologies Inc (NYSE:UBER) reported its first-ever annual profit with impressive quarterly results, outperforming Lyft in market value and user growth.

Portfolio Pulse from Upwallstreet

February 20, 2024 | 1:13 pm

SXTP

60 Degrees Pharmaceuticals, Inc. (60P) announced sponsorship of pre-clinical studies to investigate tafenoquine's efficacy against Candida spp, including the drug-resistant Candida auris. The studies, conducted by Monash University, aim to address the urgent need for effective treatments against this emerging pathogen in healthcare settings. Tafenoquine, an anti-malarial drug approved by the FDA in 2018, shows promise due to its unique mode of action. Results are expected by the end of 2024.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 1:09 pm

OGN

Organon's HADLIMA, an FDA-approved biosimilar to HUMIRA, has been exclusively selected by the US Department of Veterans Affairs to replace HUMIRA on its National Formulary. This selection is for the treatment of various autoimmune or autoinflammatory conditions.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 1:04 pm

HLIT

TIGO

Harmonic (NASDAQ:HLIT) and Millicom (NASDAQ:TIGO) have expanded their partnership with the launch of XGS-PON fiber-to-the-home (FTTH) in Latin America, leveraging Harmonic's cOS broadband platform. This move aims to provide high-speed, reliable broadband to Millicom's residential and enterprise customers across nine countries, enhancing network management and service deployment speeds. Harmonic's technology, including its Ripple hybrid fiber-cable nodes, enables strategic and cost-effective FTTH deployment, promising improved internet access and performance insights through advanced telemetry.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 1:04 pm

EVAX

MRK

Evaxion Biotech A/S has successfully completed the initial phases of its vaccine collaboration with MSD, a tradename of Merck & Co., Inc. This partnership leverages the unique capabilities and know-how of both companies in vaccine development.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 12:32 pm